Articles by Disease (Ventricular Dysfunction )

The Renin-Angiotensin System: The Role of Inhibitors, Blockers, and Genetic Polymorphisms in the Treatment and Prevention of Heart Failure

Journal: Current Vascular Pharmacology
Volume: 1
Page: 33-39
Author(s): Patricia R. Hebert, JoAnne M. Foody and Charles H. Hennekens

Cardiac Toxicity of Antineoplastic Anthracyclines

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 151-171
Author(s): Riccardo Zucchi and Romano Danesi

Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3
Page: 1-30
Author(s): Bodh I. Jugdutt

VIP and Drug Design

Journal: Current Pharmaceutical Design
Volume: 9
Page: 483-494
Author(s): Illana Gozes and Sharon Furman

Pharmacology and Therapeutic Applications of A1 Adenosine Receptor Ligands

Journal: Current Topics in Medicinal Chemistry
Volume: 3
Page: 369-385
Author(s): Arvinder K. Dhalla, John C. Shryock, Revati Shreeniwas and Luiz Belardinelli

Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?

Journal: Current Drug Targets
Volume: 3
Page: 417-425
Author(s): Peter R. Brink

Gene Therapy in Cardiovascular Diseases

Journal: Current Gene Therapy
Volume: 2
Page: 427-435
Author(s): Kamala P. Tamirisa and Debabrata Mukherjee

Galanin: A Biologically Active Peptide

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1
Page: 531-541
Author(s): Maria E. Vrontakis

Depressed or Demented: Common CNS Drug Targets? !

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1
Page: 575-592
Author(s): Miao-Kun Sun and Daniel L. Alkon

Pharmacotherapeutic Approach to Prevent or Treat Chronic Allograft Nephropathy

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 2
Page: 79-96
Author(s): E. M. Scholten, J. W. de Fijter and L. C. Paul